News & Updates

In treating nonvalvular atrial fibrillation (NVAF) patients, rivaroxaban carries a lower risk of renal decline than warfarin, a recent study has found.

Supplementation with oral magnesium for 24 weeks hardly produces any change in arterial stiffness or blood pressure (BP), as do magnesium oxide and magnesium sulphate, as shown in a study.

Chinese patients receiving androgen deprivation therapy (ADT) for prostate cancer are exposed to increased risk of new-onset diabetes mellitus (DM), hyperlipidaemia and hypertension (HTN), as well as a higher likelihood of step-up pharmacotherapy for these pre-existing conditions, according to a prospective multicentre cohort study by the Chinese University of Hong Kong (CUHK) and Tuen Mun Hospital.

A novel dual-filter device called the SENTINEL cerebral protection system (CPS) has been safely deployed in 95 percent of patients undergoing transcatheter aortic valve implantation (TAVI) with 100-percent procedural success, according to a Singapore study. No filter-related complications, stroke, or mortality has occurred at 30 days.

Longer total sitting time and prolonged sedentary bouts put women at risk of developing atrial fibrillation, a study has found.

A significant increase in blood pressure (BP) appears predictive of therapeutic response to vascular endothelial growth factor (VEGF) inhibitors but does not limit treatment duration even in patients with severe elevations, suggests a study.

Plasma levels of bile acids (BA) appear to be dependent on sex and correlate with cardiometabolic and inflammatory risk factors in young and relatively healthy adults, according to a study.

An intervention that involves informational and reminder text messages, among others, is a feasible approach for managing elevated blood pressure (BP) in the emergency department (ED) setting, as reported in a study.